Fracture at any site was diminished but did not reach statistical significance ( P = 0.10).
← all excerpts
Denosumab reduces the incidence of new vertebral fractures in men with prostate cancer.
1
0.1000
0.1000
Fracture at any site was diminished but did not reach statistical significance ( P = 0.10).